Lumendi – Lumendi

NCSG annual meeting

February 1, 2025: The NCSG annual meeting was this past weekend 2/7-2/8 at the Pinehurst Resort. I was pleased to attend this conference and had many great discussions with GI… Continue reading

LUMENDI RECEIVES CE MARK FOR DILUMEN™ EZ¹ AND DILUMEN™ C¹, EXPANDING FOOTPRINT IN THE EUROPEAN MARKET

“This certification is a key milestone in our global strategy to expand access to minimally invasive endoluminal procedures,” stated Peter Johann, Ph.D., Executive Chairman of Lumendi AG.

Lumendi Showcases Innovation and Clinical Leadership at DDW 2025

Lumendi proudly showcased its DiLumen® portfolio at DDW 2025, emphasizing innovation in advanced colorectal procedures. Our hands-on training sessions highlighted our commitment to physician education and the future of endoluminal care.

Lumendi Continues Training Future GI Leaders Through Long-Standing Industry Collaboration

February 1, 2025: Lumendi once again participated in the Advanced Hands-On Therapeutic Endoscopy Course, a quarterly training program led by Dr. Sergey Kantsevoy at the Institute for Digestive Health and… Continue reading

Experience Innovation in Action: Lumendi Unveils Revolutionary DiLumen Products at the 2024 Kings Live Event in the UK

At the 2024 Kings Live Event, Lumendi showcased the groundbreaking DiLumen EZ Glide system, demonstrating its superior capabilities in advanced endoscopic procedures through live cases led by Dr. Amyn Haji.

Lumendi Supports Advanced Gastroenterology Training at the Florida Third Space Endoscopy Workshop

Lumendi sponsored the Florida Third Space Endoscopy Workshop from November 17-19, 2024, at the AdventHealth Nicholson Center, emphasizing its commitment to advancing gastroenterology training. Participants had the opportunity to enhance their skills in Endoscopic Submucosal Dissection (ESD) techniques through hands-on sessions with Lumendi’s innovative interventional platforms.

Demonstrating Significant Time and Cost Savings in Colorectal ESD

The prospective, randomized controlled study found that DiLumen reduced total procedure time by 36.5%, leading to an average cost savings of $610.16 per patient.

The 58th Florida Gastroenterologic Society Annual Conference

Lumendi Achieves Key Milestone with Completion of DiLumen EZ¹ Customer Evaluations, Setting the Stage for the Next Phase of DiLumen Product Innovation WESTPORT, CT – July 27, 2023 Lumendi, a… Continue reading

EZ¹ successfully completes Customer Evaluation phase.

A Randomized Prospective Study Evaluating Effectiveness Of A Double Balloon Endolumenal Platform For Colorectal EndoscopicSubmucosal Dissection

Endoscopic removal of colonic polyps and early cancers eliminates the need for surgical resection and possible temporary or permanent colostomy.

Dr. Roberta Maselli, receives innovation of the year award for the best new device from the ESGE

Award for the Balloon Endo-Luminal Lumen Occluding (BELLO) Device Presented to Dr. Maselli at the ESGE Days 2023 Congress Apr 20, 2023, 12:27 ET Lumendi Congratulates Dr. Maselli on the… Continue reading Dr. Roberta Maselli, receives innovation of the year award for the best new device from the ESGE

Lumendi Receives 510(k) Clearance for Two New Devices

Company Achieves New Milestone with Over 4,000 Therapeutic Procedures Completed Across the U.S., Europe and Asia, Using DiLumen™ Endoluminal Interventional Platform February 16, 2023 08:00 AM Eastern Standard Time WESTPORT,… Continue reading

Lumendi receives 510k clearance for two new devices

Lumendi receives 510k clearance for two new devices Company Achieves New Milestone with Over 4,000 Therapeutic Procedures Completed Across the U.S., Europe and Asia, Using DiLumen™ Endoluminal Interventional Platform February… Continue reading

Lumendi Files for 510(k) Clearance for Two New Products

Company Achieves New Milestone with 3,000 Therapeutic Procedures Completed Across U.S., Europe, and Asia Using DiLumen™ EIP DiLumen EZ¹ single balloon stabilization endotherapy device. (Photo: Business Wire) May 19, 2022… Continue reading

Lumendi Files for 510(k) Clearance for Two New Products

A successful Digestive Disease Week (DDW) conference in San Diego

Since the company’s inception, we have accumulated over 100 DiLumen users worldwide. Half of these physicians have begun using our devices in the last 12 to 18 months. This year’s DDW was our first opportunity in three years to present Lumendi and our significantly enhanced DiLumen platform to users and industry.

Company Achieves New Milestone with 3,000 Therapeutic Procedures Completed Across U.S., Europe, and Asia Using DiLumen™ EIP

Prof. Dr. Peter Bauerfeind

"Stability is perfect! Maneuverability with DiLumen EZ Glide is great and the conduit function facilitates easy re-access to the right colon." Prof. Dr. Peter Bauerfeind Stadtspital Triemli, Zürich, CH

Dr. Alexander Schlachterman

“DiLumen EZ Glide provides me with effective and efficient access, which is why it is an essential ESD tool for me.” Dr. Alexander Schlachterman Thomas Jefferson University Hospital, Philadelphia,… Continue reading

Dr. Stuart Gordon

“The new DiLumen EZ Glide significantly improved our ability to remove four cecal polyps in a recent case. We could not have ever done this without it.” Dr. Stuart Gordon… Continue reading Dr. Stuart Gordon

Geisinger Medical Center, Danville, PA

“EZ Glide represents a huge improvement in usability of DiLumen technology. The enhanced ease of use has prompted me to use DiLumen more often for complex colonic polypectomies.” Dr. David… Continue reading Geisinger Medical Center, Danville, PA

DiLumen EIP is now even easier to use with EZ-Glide hydrophilic coating

DiLumen EZ-Glide improves visibility and simplifies intraoperative

Lumendi receives 510k clearance for two new devices

Lumendi Reports Successful Completion Of Dilumen™ Eip First-in-human Trials

LUMENDI REPORTS SUCCESSFUL COMPLETION OF DILUMEN™ EIP FIRST-IN-HUMAN TRIALS Primary Study Endpoint Reached with no Serious Adverse Events WESTPORT, CONNECTICUT, November 16, 2017 – Connecticut-based medical device innovator Lumendi,… Continue reading

Thank you to Prof. Peter Bauerfeind and Dr. Hugo Uchima

Thank you to Prof. Peter Bauerfeind and Dr. Hugo Uchima for a great workshop in Lucerne. The international group of endoscopists enjoyed the educational value and the practical experience of… Continue reading

Thank you for supporting our Patient Awareness Initiative

30% of surgical interventions are unnesessary

Dr. Peter Johann, CEO & Founder of Lumendi and Prof. Bauerfeind discussed how treatment methods such as EMR and ESD can be made more accessible to patients. Prof. Bauerfeind: "Sometimes these treatments… Continue reading

Lumendi Announces CMS HCPCS Code for Reimbursement of ESD Procedures Performed in Hospital Outpatient Facilities

October 19, 2021 08:00 AM Eastern Daylight Time WESTPORT, Conn.--(BUSINESS WIRE)--Lumendi-- Effective October 1, 2021, the Centers for Medicare & Medicaid Services (CMS) established C9779 as a new Healthcare… Continue reading

EZ Glide Pushes Lumendi to New Quarter-Over-Quarter Sales Record

DiLumen® Product Enhancement Launched in December 2020 on Track to Double Sales from Previous Year September 28, 2021 WESTPORT, Conn.--(BUSINESS WIRE)-- EZ Glide, the most recent enhancement to Lumendi’s DiLumen Endoluminal Interventional… Continue reading

Invitation Skills Lab, Switzerland

INTRODUCING LUMENDI'S LATEST INNOVATION At Lumendi, we’re committed to creating technologies that enable physicians to perform at a higher level, minimize risk and recovery time for patients. We invite you… Continue reading

Introducing Lumendi’s latest Innovation in Asia

Innovative Surgical Platform Improves the Safety and Speed of Endolumenal Procedures For patients with complex benign colorectal polyps, surgical intervention tends to be the norm. Yet, endoluminal procedures like endoscopic… Continue reading

Introducing EZ Glide in Europe

Many studies have documented that an endoscopic approach for ESD is a safer and less expensive alternative to removing these polyps, leading to fewer postoperative complications and shorter hospital stays.

Lumendi Introduces EZ Glide Hydrophilic Coating for Its DiLumen Endoluminal Interventional Platform (EIP™)

Lumendi Platforms to be Discussed in Investor’s Webcast 31 March 2021 with Panel of Clinical Experts New EZ Glide, activated by water or saline, improves endoscopic performance of the DiLumen… Continue reading

DiLumen online

Online Support for Clinical Cases With the current restrictions travel and in-house visits are often limited or impossible. The Lumendi team will continue to support you with the use of… Continue reading

ASGE Webinar Online

Upcoming ASGE Webinar: Navigating the Tortuous Colon Reimbursement for Complex Endoscopic Resection January 14th at 8pm EST (7pm CST) Join ASGE staff and Dr. Othman as they cover the following:… Continue reading

Superiority of DiLumen over traditional (non-overtube) ESD for complex colorectal polypectomy.

Superiority of DiLumen over traditional (non-overtube) ESD for complex colorectal polypectomy.
Removing colorectal polyps and early cancers by endoscope eliminates the need for surgical resection and the potential for colostomy. This study reports clear improvements in safety, dissection time, dissection speed, R0 resection rates (clean pathological margins), and navigation time over non-DiLumen-assisted (freehand) procedures.

The Cost-Effectiveness of DiLumen^TM for Endoscopic Intervention of Complex Colonic Polyps

The Cost-Effectiveness of DiLumenTM for Endoscopic Intervention of Complex Colonic Polyps
James White, D.O., VP of Medical Affairs, Lumendi
Karl Florence, Reimbursement Consultant.

PIONEERING ENDOSURGERY NEW MISSION STATEMENT AT LUMENDI

Pioneering Endosurgery reflects Lumendi’s innovative, three-part pathway to:

expand indication areas and procedures in the upper gastrointestinal tract, which includes a recent submission to the FDA;
innovate improvements planned for the DiLumen EIP, including a proprietary lubricated inner surface of DiLumen’s sheath for better endoscope handling performance; and
commercially release the DiLumen C2 platform[1] to bring robotic-like end-effectors to endolumenal surgery in a low-cost, disposable format to provide endoscopists with unprecedented control of tissue.

LUMENDI REPORTS FIRST INCISIONLESS APPENDECTOMY USING DOUBLE-BALLOON ENDOLUMENAL INTERVENTIONAL PLATFORM

Dr. Kantsevoy states, “Endoscopic endolumenal appendectomy is less invasive than traditional surgical, laparoscopic, transvaginal or transgastric appendectomy.

Early Trial Data Show Promise in Endoscopic Procedure Time Study

A study evaluating endoscopic procedure time removing complex colorectal polyps shows superiority of Lumendi’s DiLumen device over a control group.

LUMENDI OPERATIONS AND CLINICAL SUPPORT REMAIN AVAILABLE DURING OBSERVANCE OF COVID-19 PRECAUTIONS.

We have adapted our operation and clinical support models as healthcare facilities prioritize focus on patients affected by COVID-19.

LUMENDI REPORTS SUCCESSFUL ENROLLMENT CLOSURE OF ITS DILUMEN™ ENDOLUMENAL INTERVENTIONAL PLATFORM (EIP™) STUDY

The study evaluates DiLumen’s effect on endoscopic procedure time for pre-cancerous colorectal complex polypectomies.

LARGE COMPLEX POLYPS REMOVED SUCCESSFULLY FROM THREE PATIENTS WITHOUT SURGICAL INTERVENTION USING LUMENDI DILUMEN C2™

The first successful case at Cleveland Clinic using DiLumen C2 was completed by Dr. Gorgun when a large complex polyp in the distal sigmoid, 18cm from the anus was removed from a 72-year-old woman with a narrow sigmoid.

LUMENDI RECEIVES 510(k) CLEARANCE FOR DILUMEN Ik™ ENDOLUMENAL INTERVENTIONAL KNIFE

1000 Therapeutic Procedures Using DiLumen™ EIP Completed Across U.S., Europe and Asia WESTPORT, CONN, August 20, 2019 − Connecticut-based medical device innovator Lumendi, LLC (http://www.lumendi.com) has announced it has received U.S.… Continue reading

A new platform to facilitate exposure of difficult-to-access lesions has been designed

As seen on Endoscopic submucosal dissection of a laterally spreading tumor in the right colon with a gastroscope after shortening the colon using a new double-balloon platform Endoscopic submucosal dissection… Continue reading

LUMENDI RECEIVES FDA 510(k) CLEARANCE FOR DILUMEN C2^TM

Second Generation Endoscopic Accessory for Endolumenal Procedures WESTPORT, CONN, April 23, 2018 – Connecticut-based medical device innovator Lumendi, LLC has announced it has received United States Food and Drug Administration… Continue reading

MEDICAL MARVELS with Eyewitness News

MEDICAL MARVELS Dual balloon endoscope device reduces the need for surgery to remove polyps. As seen on Eyewitness News | Tuesday, January 29, 2019 12:00AM UPPER EAST SIDE, Manhattan… Continue reading

LUMENDI RECEIVES FDA 510(k) CLEARANCE FOR INNOVATIVE DILUMEN^™ EIP DEVICE MODIFICATION TO IMPROVE TISSUE RETRACTION DURING THERAPEUTIC ENDOSCOPY

With recent regulatory approvals in Europe, Lumendi has established distribution in the UK, France and Italy and has conducted successful procedures with clinicians in each country.

500 THERAPEUTIC PROCEDURES USING DILUMEN^™ EIP COMPLETED ACROSS U.S., EUROPE AND ASIA

WESTPORT, CONN, OCTOBER 4, 2018 − Connecticut-based medical device innovator Lumendi, LLC reports that more than 500 therapeutic procedures by more than 40 endoscopists and colorectal surgeons have been completed… Continue reading

LUMENDI EXPANDS TEAM WITH NEW VP OF SALES, MICHAEL R. THOMAS

WESTPORT, CT, August 21, 2018 – Connecticut-based medical device innovator Lumendi, LLC is again expanding its team as Michael R. Thomas joins as Vice President of Sales. Mr. Thomas is… Continue reading

LUMENDI OPENS EU MARKET FOR DILUMEN EIP^™

CE Certification Confirms Device Conforms to Medical Device Directive 93/42/EEC BUCKINGHAMSHIRE, UK, JULY 17, 2018 -- Lumendi Ltd., a privately held innovative medical device company, today announced that its subsidiary,… Continue reading

FLEXIBLE ENDOSCOPIC DOUBLE BALLOON PLATFORM: FROM CONCEPT TO HUMAN FEASIBILITY TRIAL

Flexible Endoscopic Double Balloon Platform: from concept to human feasibility trial. Sam Sharma*, Kota Momose, Toyooki Sonoda, Reem Z. Sharaiha Weill Cornell Medical College, New York, NY Background: Despite the… Continue reading

LUMENDI RECEIVES FDA 510(k) CLEARANCE FOR DILUMEN Is^™ ENDOLUMENAL INTERVENTIONAL SCISSORS

Second Generation Endoscopic Accessory for Endolumenal Procedures WESTPORT, CONN, May 29, 2018 − Connecticut-based medical device innovator Lumendi, LLC has announced it has received United States Food and Drug Administration… Continue reading

LUMENDI RECEIVES FDA 510(k) CLEARANCE FOR DILUMEN C2^TM

Lumendi to Present at Digital Medicine & Medtech Showcase

Lumendi to Present at Digital Medicine & Medtech Showcase WESTPORT, CONN, November 10, 2017 – Lumendi Ltd., a privately held innovative medical device company, announced today that Chief Executive Officer… Continue reading

Stabilizing The Scope: How The DiLumen EIP Changes Intestinal Surgery

Stabilizing The Scope: How The DiLumen EIP Changes Intestinal Surgery Daniel Seeger Editor with www.surgicalproductsmag.com Surgeons interested in expanding their alternatives in pursuing minimally invasive options need to be attuned to… Continue reading

DILUMEN™ EIP COMPLETES 100 THERAPEUTIC PROCEDURES ACROSS UNITED STATES

DILUMEN™ EIP COMPLETES 100 THERAPEUTIC PROCEDURES ACROSS UNITED STATES WESTPORT, CONN, DECEMBER 6, 2017 − Connecticut-based medical device innovator Lumendi, LLC reports it has successfully completed more than 100 therapeutic procedures… Continue reading

LUMENDI REPORTS SUCCESSFUL COMPLETION OF DILUMEN™ EIP FIRST-IN-HUMAN TRIALS

LUMENDI’S DILUMEN Ig™ ENDOLUMENAL INTERVENTIONAL GRASPER FOR MINIMALLY INVASIVE ENDOSCOPIC THERAPIES NOW AVAILABLE IN U.S.

LUMENDI’S DILUMEN Ig™ ENDOLUMENAL INTERVENTIONAL GRASPER FOR MINIMALLY INVASIVE ENDOSCOPIC THERAPIES NOW AVAILABLE IN U.S. Lumendi Submits Premarket Notification to US FDA For DiLumen C2™ and the DiLumen Is™ as Part… Continue reading

LUMENDI EXPANDS MEDICAL ADVISORY BOARD WITH THREE GLOBAL EXPERTS IN ADVANCED ENDOSCOPY

LUMENDI EXPANDS MEDICAL ADVISORY BOARD WITH THREE GLOBAL EXPERTS IN ADVANCED ENDOSCOPY Dr. Sergey V. Kantsevoy, Professor Alessandro Repici and Professor Kazuki Sumiyama to help guide improvements in endoscopic interventions… Continue reading

LUMENDI EXPANDS SOCIAL MEDIA PRESENCE

LUMENDI EXPANDS SOCIAL MEDIA PRESENCE WITH NEW YOU TUBE CHANNEL DEDICATED TO ITS DILUMEN™ EIP WESTPORT, CONNECTICUT, October 4, 2017 – Lumendi, LLC (http:/lumendi.com), a wholly owned subsidiary of Lumendi,… Continue reading